Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 3
2005 2
2006 1
2008 1
2009 2
2010 1
2011 2
2012 1
2014 1
2015 2
2016 3
2018 6
2019 3
2020 1
2021 2
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
CD99 at the crossroads of physiology and pathology.
Pasello M, Manara MC, Scotlandi K. Pasello M, et al. J Cell Commun Signal. 2018 Mar;12(1):55-68. doi: 10.1007/s12079-017-0445-z. Epub 2018 Jan 6. J Cell Commun Signal. 2018. PMID: 29305692 Free PMC article. Review.
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC, Manferdini C, Cristalli C, Carrabotta M, Santi S, De Feo A, Caldoni G, Pasello M, Landuzzi L, Lollini PL, Salamanna F, Dominici S, Fiori V, Magnani M, Lisignoli G, Scotlandi K. Manara MC, et al. Among authors: pasello m. Cancer Immunol Res. 2024 Feb 2;12(2):247-260. doi: 10.1158/2326-6066.CIR-23-0440. Cancer Immunol Res. 2024. PMID: 38051221 Free PMC article.
Editorial: New therapies in the treatment of sarcomas.
Gartland A, Pasello M, Lézot F, Lamoureux F. Gartland A, et al. Among authors: pasello m. Front Endocrinol (Lausanne). 2023 Jan 18;14:1137736. doi: 10.3389/fendo.2023.1137736. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742406 Free PMC article. No abstract available.
Emerging drugs for high-grade osteosarcoma.
Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M. Hattinger CM, et al. Among authors: pasello m. Expert Opin Emerg Drugs. 2010 Dec;15(4):615-34. doi: 10.1517/14728214.2010.505603. Epub 2010 Aug 9. Expert Opin Emerg Drugs. 2010. PMID: 20690888 Review.
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K. Carrabotta M, et al. Among authors: pasello m. Cancer Res. 2022 Feb 15;82(4):708-720. doi: 10.1158/0008-5472.CAN-21-1222. Cancer Res. 2022. PMID: 34903601 Free PMC article.
Construction of Human Naïve Antibody Gene Libraries.
Pasello M, Mallano A, Flego M, Zamboni S, Giudice AM, Scotlandi K. Pasello M, et al. Methods Mol Biol. 2018;1827:73-91. doi: 10.1007/978-1-4939-8648-4_4. Methods Mol Biol. 2018. PMID: 30196492
40 results